Literature DB >> 8990443

Human papillomavirus in squamous cell carcinoma of the vulva by polymerase chain reaction.

A Iwasawa1, P Nieminen, M Lehtinen, J Paavonen.   

Abstract

OBJECTIVE: To investigate the prevalence of human papillomavirus (HPV) DNA in squamous cell carcinoma of the vulva by polymerase chain reaction (PCR).
METHODS: Archival diagnostic phase biopsies from 74 patients with squamous cell carcinoma of the vulva were investigated for HPV DNA by PCR. We used both consensus primers located in the open reading frame L1 and type-specific primers for HPV 6 (open reading frame E5), HPV 11 (open reading frame L1), HPV 16, HPV 18, and HPV 33 (open reading frame E6).
RESULTS: HPV DNA was detected in 27 (36%) of the 74 patients, of whom 19 had HPV 16, nine had HPV 18, one had HPV 33, and one had unclassified HPV DNA. No case of HPV type 6 or 11 was detected. Two squamous cell carcinomas were positive for both HPV 16 and 18, and one was positive for both HPV types 16 and 33. Three squamous cell carcinomas positive for E6 gene using type-specific primers were negative using L1 consensus primers.
CONCLUSION: Our PCR methods using both consensus open reading frame L1-derived primers and type-specific open reading frame E6-derived primers of HPV types 16, 18, and 33 seemed to be an appropriate combination for the detection of HPV DNA in archival tissues of vulvar carcinoma. Both HPV types 16 and 18 were associated with squamous cell carcinoma of the vulva, although the prevalence of HPV 16 was considerably lower than in cervical carcinoma. It appears that vulvar and cervical carcinomas are not identical etiologically and that factors other than HPV are important in vulvar carcinogenesis.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 8990443     DOI: 10.1016/s0029-7844(96)00376-6

Source DB:  PubMed          Journal:  Obstet Gynecol        ISSN: 0029-7844            Impact factor:   7.661


  8 in total

1.  Cell cycle suppressor proteins are not related to HPV status or clinical outcome in patients with vulvar carcinoma.

Authors:  André Mourão Lavorato-Rocha; Iara Sant'ana Rodrigues; Beatriz de Melo Maia; Mônica Maria Ágata Stiepcich; Glauco Baiocchi; Kátia Cândido Carvalho; Fernando Augusto Soares; José Vassallo; Rafael Malagoli Rocha
Journal:  Tumour Biol       Date:  2013-07-06

2.  Tumor proteomics by multivariate analysis on individual pathway data for characterization of vulvar cancer phenotypes.

Authors:  Annsofi Sandberg; Gunnel Lindell; Brita Nordström Källström; Rui Mamede Branca; Kristina Gemzell Danielsson; Mats Dahlberg; Barbro Larson; Jenny Forshed; Janne Lehtiö
Journal:  Mol Cell Proteomics       Date:  2012-04-12       Impact factor: 5.911

Review 3.  The economic burden of noncervical human papillomavirus disease in the United States.

Authors:  Delphine Hu; Sue Goldie
Journal:  Am J Obstet Gynecol       Date:  2008-05       Impact factor: 8.661

4.  Establishment and characterization of two squamous cell carcinoma cell lines (HYVC and HMVC) derived from vulva.

Authors:  Kazushige Kiguchi; Isamu Ishiwata; Chieko Ishiwata; Masanori Iwata; Bunpei Ishizuka; Hiroyuki Yoshikawa; Toshiaki Tachibana; Hisashi Hashimoto; Hiroshi Ishikawa
Journal:  Hum Cell       Date:  2002-12       Impact factor: 4.174

5.  Genotyping of human papillomaviruses by a novel one-step typing method with multiplex PCR and clinical applications.

Authors:  Morie Nishiwaki; Tomohiro Yamamoto; Somako Tone; Taichi Murai; Tatsuya Ohkawara; Takakuni Matsunami; Motoiki Koizumi; Yoshitake Takagi; Jun Yamaguchi; Nobuo Kondo; Jun Nishihira; Takeharu Horikawa; Takashi Yoshiki
Journal:  J Clin Microbiol       Date:  2008-01-30       Impact factor: 5.948

6.  Prevention of cervical, vaginal, and vulval cancers: role of the quadrivalent human papillomavirus (6, 11, 16, 18) recombinant vaccine.

Authors:  Maria Lina Diaz
Journal:  Int J Womens Health       Date:  2010-08-09

7.  Vulvar Cancer in China: Epidemiological Features and Risk Analysis.

Authors:  Xue Xiao; Yi-Bo Meng; Peng Bai; Juan Zou; Ya Zhang; Tri M Bui Nguyen; Jian-Guo Xiao; Xue-Mei Gao; Bang-Fen Wen
Journal:  J Cancer       Date:  2017-08-25       Impact factor: 4.207

8.  Patients with usual vulvar intraepithelial neoplasia-related vulvar cancer have an increased risk of cervical abnormalities.

Authors:  R P de Bie; H P van de Nieuwenhof; R L M Bekkers; W J G Melchers; A G Siebers; J Bulten; L F A G Massuger; J A de Hullu
Journal:  Br J Cancer       Date:  2009-06-09       Impact factor: 7.640

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.